Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Epidemiology news

Show

From To
DfID recommend slashing 100 projects to help the world’s poor

Civil servants in the Department for International Development are recommending that Ministers drop close to 100 public commitments including many with “strong public backing”. Among those for the chop are commitments to double support to global education and to spend £6 billion of new money on health services and systems.

Published
13 August 2010
From
Left Foot Forward
Ministers advised to drop dozens of aid projects

Ministers have been advised to scrap dozens of overseas aid projects including funding to eradicate polio and put children in Africa through school, a leaked report has disclosed.

Published
13 August 2010
From
Daily Telegraph
HIV is a 20th-century disease that needs 21st-century research

We need smarter approaches to clinical trials that test more concepts in less time, for less money, while preserving safety, community engagement and ethical guidelines, say Alan Bernstein and Peter Piot.

Published
10 August 2010
From
The Globe and Mail
Uganda: Pepfar Makes U-Turn

Advocacy organisations in the US and Uganda have welcomed the announcement that the U.S. global AIDS program, PEPFAR, has reversed severe restrictions that capped enrollment of new HIV patients on life saving treatment in Uganda.

Published
04 August 2010
From
AllAfrica
Analysis: HIV generics under threat from tighter patenting rules

Most of the estimated 5.2 million people worldwide on antiretroviral (ARV) treatment are taking generic versions manufactured primarily in India, but tighter global intellectual property rights and trade rules could shut down "the pharmacy of the developing world".

Published
02 August 2010
From
IRIN Plus News
Almost Everyone Into the Patent Pool

Three leading HIV drugmakers—Merck, Gilead, and Tibotec—have agreed to license their entire HIV portfolios to the UNITAID patent pool, not excluding best-selling, state-of-the-art products like Merck’s novel Isentress, Gilead’s fixed-dose combo Truvada, and Tibotec’s resistance-busting Prezista.

Published
30 July 2010
From
PharmExec.com
Bill Clinton Was Right About Wasted HIV/AIDS Funding

Dollars desperately needed to save lives of AIDS patients have never left Washington or have been wasted on unnecessary overhead around the world.

Published
29 July 2010
From
Huffington Post
Africa: Partner Countries Must be Held Responsible for Their Populations, Says Head of Pepfar

"Our partner governments don’t feel the need to increase or maintain funding as PEPFAR or Global Fund resources come into their countries. We need to hold our partner countries responsible for their populations and they need to maintain and increase funding lines."

Published
26 July 2010
From
IRIN Plus News
China, India should open wallets for AIDS war: Global Fund

China, India and other fast-growing economies should start to contribute to the world's war chest to fight AIDS, the head of the Global Fund said on Friday.

Published
23 July 2010
From
Yahoo / AFP
Tutu: Obama’s Broken AIDS Promise

"I am saddened by his decision to spend less than he promised to treat AIDS patients in Africa," says Archbishop Desmond Tutu.

Published
21 July 2010
From
New York Times

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.